Access to essential medicines is seen as the key barrier to health in developing countries, by governments and corporates alike[1]. The pharmaceutical industry and those involved in delivering patient healthcare often frame the issues surrounding ‘access’ as three – or sometimes four – ‘As for Access’. ColaLife has looked at models of patient access covering, […]
Endline Survey Report published
22 July 2014 by
During the ColaLife Operational Trial Zambia (COTZ) three sets of surveys were carried out: a baseline; midline (after 6 months) and endline. All surveys included a household survey and a survey of retailers. The midline and endline also looked at the impact we were having on the rural health centres in the trial sites. Technical […]
